Chinese and Western medicine for severe pneumonia from drug-resistant bacteria
Part of Infections, Lungs & breathing clinical trials.
This trial tests a combination of traditional Chinese and Western medicine for adults with severe pneumonia caused by bacteria that are resistant to multiple antibiotics. It aims to see if this combined approach can improve treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 79 years old and have severe pneumonia.
- Your pneumonia is caused by a type of bacteria that is resistant to at least three different antibiotic classes.
- You or your legal guardian agree to the study and sign a consent form.
- You are not pregnant or breastfeeding.
- You do not have other serious lung infections like tuberculosis, fungal pneumonia, or viral pneumonia.
- You have not been on antibiotics for this pneumonia for more than one week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding traditional Chinese medicine to standard care helps people with pneumonia caused by bacteria that are hard to treat with many antibiotics. It may offer another option to fight the infection.
This study looks at whether traditional Chinese medicine can help people with severe pneumonia. If you join, you'll receive this treatment as part of your care, and the researchers will track how well it works.
This trial tests a new approach combining a traditional Chinese medicine formula with bacteriophages (viruses that attack bacteria) to treat severe pneumonia caused by antibiotic-resistant bacteria. It aims to see if this combination can improve outcomes for patients who have limited treatment options.
This study tests a Chinese herbal medicine called Fei Re Qing granules for older adults with pneumonia. It may help reduce symptoms like cough and phlegm when started early.
This trial tests a Chinese herbal formula combined with virus-based therapy (bacteriophages) to treat severe pneumonia caused by antibiotic-resistant bacteria. It may offer a new option when standard antibiotics fail.
This trial tests whether adding an experimental herbal medicine (NRICM102) to standard antibiotics can help adults hospitalized with community-acquired pneumonia recover faster. It is a phase 2 study, meaning the treatment is still being tested for safety and effectiveness.
Hear when a new Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.